placeholder image
E. S. Strock All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes. 
    Journal of Diabetes and Its Complications. 2022
  • Evaluation of insulin glargine and exenatide alone and in combination: a randomized clinical trial with continuous glucose monitoring and ambulatory glucose profile analysis. 
    Endocrine Practice. 2019
  • Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: an analysis using continuous glucose monitoring. 
    Diabetes/Metabolism Research and Reviews. 2017
  • Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes. 
    Mayo Clinic Proceedings. 2015
  • A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes. 
    Diabetes care. 2014
  • Diurnal glucose profiles using continuous glucose monitoring to identify the glucose-lowering characteristics of colesevelam HCl (Welchol). 
    Endocrine Practice. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). 
    Diabetes Technology & Therapeutics. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. 
    Journal of Diabetes Science and Technology. 2013
  • International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece. 
    Diabetes Technology & Therapeutics. 2011
  • Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis. 
    Endocrine Practice. 2009
  • Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time?. 
    Diabetes Technology & Therapeutics. 2009
  • Implementation of a systematic approach to diabetes in primary care in Bahia, Brazil improves metabolic outcomes: PRODIBA-Programa de Interiorizacao da Assistencia ao Diabetes na Bahia (Project for Dissemination of Diabetes Care in the State of Bahia). 
    Diabetic Medicine. 2009
  • Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. 
    Diabetes Technology & Therapeutics. 2008
    • Abstract
  • Glycemic variability correlated with 1.5-anhydroglucitol (1.5 AHG) but not with markers of oxidation, inflammation, and endothelial function: baseline characteristics of the CAROLINA CGM sub-study [abstract]. 
    Diabetes. 2015
    • Book
  • China Initiative for Diabetes Excellence (CIDE): clinical status of 2143 individuals from 27 provinces with type 2 diabetes
    2013
  • Implementation of programs for community healthcare providers and patients in China
    2013
    • Contact
    full name
  • E. S. Strock
    • Quick Info
     
    Collaboration